Wei Lin
SEC CIK 1872772 · EDGAR
BoughtSold
Most active insiders at RVMD, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | GOLDSMITH MARK A | See Remarks, Dir | — | $56.99M |
| 2 | Kelsey Stephen Michael | See Remarks | — | $22.55M |
| 3 | Cislini Jeff | SVP, GC | — | $15.19M |
| 4 | Kim Lorence H. | Dir | — | $14.97M |
| 5 | Horn Margaret A | COO | — | $10.84M |
| 6 | Mancini Anthony | See Remarks | — | $9.05M |
| 7 | Anders Jack | CFO | — | $7.13M |
| 8 | ANDERSON ELIZABETH M | Dir | — | $1.96M |
| 9 | Patel Sushil | Dir | — | $1.05M |
| 10 | Wei Lin | Chief Medical Off | — | $206.2K |
Transactions 8
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-03-19 | 2026-03-17 | RVMD | Revolution Medicines, Inc. | Wei Lin | Chief Medical Off | S - Sale | $99.48 | -2,073 | 101.4K | -2% | -$206.2K |
| D | 2026-03-03 | 2026-03-01 | RVMD | Revolution Medicines, Inc. | Wei Lin | Chief Medical Off | A - Grant | $0.00 | +15.1K | 103.4K | +17% | $0 |
| T | 2025-09-18 | 2025-09-16 | RVMD | Revolution Medicines, Inc. | Wei Lin | Chief Medical Off | S - Sale | $45.82 | -2,160 | 88.3K | -2% | -$99.0K |
| T | 2025-06-18 | 2025-06-16 | RVMD | Revolution Medicines, Inc. | Wei Lin | Chief Medical Off | S - Sale | $39.83 | -2,173 | 90.5K | -2% | -$86.6K |
| D | 2025-03-04 | 2025-03-01 | RVMD | Revolution Medicines, Inc. | Wei Lin | Chief Medical Off | A - Grant | $0.00 | -20.8K | 91.7K | -18% | $0 |
| 2024-06-20 | 2024-06-17 | RVMD | Revolution Medicines, Inc. | Wei Lin | Chief Medical Off | S - Sale | $37.39 | -5,589 | 70.9K | -7% | -$209.0K | |
| DM | 2023-02-03 | 2023-02-01 | ERAS | Erasca, Inc. | Wei Lin | Chief Medical Off | J - Other | $4.10 | +1,750 | 315.8K | +0.6% | +$7,175 |
| D | 2022-02-03 | 2022-02-01 | ERAS | Erasca, Inc. | Wei Lin | Chief Medical Off | J - Other | $11.60 | +1,562 | 314.1K | +0.5% | +$18.1K |
Purchase Sale Sale after option exercise All abbreviations